HEADER CHAPERONE 10-DEC-10 2Y1Z TITLE HUMAN ALPHAB CRYSTALLIN ACD R120G COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-CRYSTALLIN B CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ALPHA-CRYSTALLIN DOMAIN (ACD), RESIDUES 67-157; COMPND 5 SYNONYM: ALPHAB-CRYSTALLIN, ALPHA(B)-CRYSTALLIN, HEAT SHOCK PROTEIN COMPND 6 BETA-5, HSPB5, RENAL CARCINOMA ANTIGEN NY-REN-27, ROSENTHAL FIBER COMPND 7 COMPONENT; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PPROEX HT(B) KEYWDS SMALL HEAT SHOCK PROTEIN, CHAPERONE, STRESS PROTEIN, EYE LENS KEYWDS 2 PROTEIN, CATARACT EXPDTA X-RAY DIFFRACTION AUTHOR A.R.CLARK,C.BAGNERIS,C.E.NAYLOR,N.H.KEEP,C.SLINGSBY REVDAT 2 13-APR-11 2Y1Z 1 JRNL REMARK REVDAT 1 02-MAR-11 2Y1Z 0 JRNL AUTH A.R.CLARK,C.E.NAYLOR,C.BAGNERIS,N.H.KEEP,C.SLINGSBY JRNL TITL CRYSTAL STRUCTURE OF R120G DISEASE MUTANT OF HUMAN JRNL TITL 2 ALPHAB-CRYSTALLIN DOMAIN DIMER SHOWS CLOSURE OF A GROOVE JRNL REF J.MOL.BIOL. V. 408 118 2011 JRNL REFN ISSN 0022-2836 JRNL PMID 21329698 JRNL DOI 10.1016/J.JMB.2011.02.020 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.BAGNERIS,O.A.BATEMAN,C.E.NAYLOR,N.CRONIN,W.C.BOELENS, REMARK 1 AUTH 2 N.H.KEEP,C.SLINGSBY REMARK 1 TITL CRYSTAL STRUCTURES OF ALPHA-CRYSTALLIN DOMAIN DIMERS OF REMARK 1 TITL 2 ALPHAB-CRYSTALLIN AND HSP20. REMARK 1 REF J.MOL.BIOL. V. 392 1242 2009 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 19646995 REMARK 1 DOI 10.1016/J.JMB.2009.07.069 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 96.88 REMARK 3 NUMBER OF REFLECTIONS : 6777 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.18047 REMARK 3 R VALUE (WORKING SET) : 0.17335 REMARK 3 FREE R VALUE : 0.24052 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.4 REMARK 3 FREE R VALUE TEST SET COUNT : 788 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.499 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.563 REMARK 3 REFLECTION IN BIN (WORKING SET) : 469 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.219 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1359 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.7 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.194 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.51 REMARK 3 B22 (A**2) : 6.51 REMARK 3 B33 (A**2) : -13.02 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.104 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.060 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.189 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 18.426 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1416 ; 0.006 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1915 ; 0.964 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 176 ; 5.338 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 70 ;31.642 ;23.714 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 243 ;14.405 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;15.055 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 209 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1068 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 862 ; 0.213 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1395 ; 0.410 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 554 ; 0.662 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 517 ; 1.128 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 2 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 70 A 105 6 REMARK 3 1 B 70 B 105 6 REMARK 3 2 A 116 A 145 6 REMARK 3 2 B 116 B 145 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 A (A): 495 ; 0.41 ; 5.00 REMARK 3 LOOSE POSITIONAL 1 B (A): 495 ; 0.41 ; 5.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 495 ; 2.49 ; 50.00 REMARK 3 LOOSE THERMAL 1 B (A**2): 495 ; 2.49 ; 50.00 REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : 1.000H, 1.000K, L REMARK 3 TWIN FRACTION : 0.530 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : -1.000H, -1.000K, L REMARK 3 TWIN FRACTION : 0.470 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 67 A 151 REMARK 3 ORIGIN FOR THE GROUP (A): 23.8861 -12.2649 16.8092 REMARK 3 T TENSOR REMARK 3 T11: 0.0695 T22: 0.0601 REMARK 3 T33: 0.0353 T12: -0.0067 REMARK 3 T13: -0.0192 T23: -0.0352 REMARK 3 L TENSOR REMARK 3 L11: 5.5770 L22: 2.2609 REMARK 3 L33: 2.5683 L12: 0.3762 REMARK 3 L13: -1.8595 L23: -0.6351 REMARK 3 S TENSOR REMARK 3 S11: -0.0203 S12: 0.0410 S13: -0.0442 REMARK 3 S21: 0.0177 S22: -0.0537 S23: 0.0167 REMARK 3 S31: 0.0987 S32: 0.0169 S33: 0.0740 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 65 B 150 REMARK 3 ORIGIN FOR THE GROUP (A): 36.8936 -10.6911 -3.1666 REMARK 3 T TENSOR REMARK 3 T11: 0.0762 T22: 0.0871 REMARK 3 T33: 0.0696 T12: 0.0213 REMARK 3 T13: -0.0330 T23: 0.0339 REMARK 3 L TENSOR REMARK 3 L11: 2.0483 L22: 1.4292 REMARK 3 L33: 1.6936 L12: -0.7175 REMARK 3 L13: -1.1311 L23: 0.8062 REMARK 3 S TENSOR REMARK 3 S11: -0.0135 S12: 0.0401 S13: -0.0867 REMARK 3 S21: 0.0423 S22: -0.0278 S23: -0.0799 REMARK 3 S31: -0.0595 S32: -0.1654 S33: 0.0413 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2Y1Z COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-DEC-10. REMARK 100 THE PDBE ID CODE IS EBI-46652. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7582 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.50 REMARK 200 RESOLUTION RANGE LOW (A) : 46.60 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 9.2 REMARK 200 R MERGE (I) : 0.10 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.40 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 9.1 REMARK 200 R MERGE FOR SHELL (I) : 0.54 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.30 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASOR REMARK 200 STARTING MODEL: HUMAN ALPHA-CRYSTALLIN DOMAIN RESIDUES 71- REMARK 200 157 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.6 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 16.5 MG/ML IN BUFFER REMARK 280 (25 MM TRISHCL, PH 7.5, 25 MM NACL) WAS MIXED 1:1 WITH REMARK 280 MOTHER LIQUOR (36% MPD, 0.18M POTASSIUM CHLORIDE) REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.76667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.38333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 33.38333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 66.76667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 120 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 137 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ARG 120 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LEU 137 TO SER REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 64 REMARK 465 ALA A 65 REMARK 465 MET A 66 REMARK 465 VAL A 152 REMARK 465 SER A 153 REMARK 465 GLY A 154 REMARK 465 PRO A 155 REMARK 465 GLU A 156 REMARK 465 ARG A 157 REMARK 465 GLN B 151 REMARK 465 VAL B 152 REMARK 465 SER B 153 REMARK 465 GLY B 154 REMARK 465 PRO B 155 REMARK 465 GLU B 156 REMARK 465 ARG B 157 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 67 CG CD OE1 OE2 REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 LYS A 92 CD CE NZ REMARK 470 LEU A 94 CG CD1 CD2 REMARK 470 ARG A 107 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 150 CD CE NZ REMARK 470 GLN A 151 CG CD OE1 NE2 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 LYS B 92 CD CE NZ REMARK 470 LYS B 150 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 109 -131.79 164.80 REMARK 500 GLU B 110 68.26 -111.97 REMARK 500 HIS B 111 -45.13 -130.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD A1152 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A1153 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD B1151 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD B1152 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WJ7 RELATED DB: PDB REMARK 900 HUMAN ALPHAB CRYSTALLIN REMARK 900 RELATED ID: 2Y1Y RELATED DB: PDB REMARK 900 HUMAN ALPHAB CRYSTALLIN ACD(RESIDUES 71-157) REMARK 900 RELATED ID: 2Y22 RELATED DB: PDB REMARK 900 HUMAN ALPHAB-CRYSTALLIN DOMAIN (RESIDUES 67-157) REMARK 999 REMARK 999 SEQUENCE REMARK 999 R120G IS A DISEASE ASSOCIATED MUTATION L137M TO ALLOW REMARK 999 CRYSTALISATION. ALPHA-CRYSTALLIN DOMAIN ONLY. HUMAN REMARK 999 ALPHAB CRYSTALLIN ACD(RESIDUES 67-157) DBREF 2Y1Z A 67 157 UNP P02511 CRYAB_HUMAN 67 157 DBREF 2Y1Z B 67 157 UNP P02511 CRYAB_HUMAN 67 157 SEQADV 2Y1Z GLY A 64 UNP P02511 EXPRESSION TAG SEQADV 2Y1Z ALA A 65 UNP P02511 EXPRESSION TAG SEQADV 2Y1Z MET A 66 UNP P02511 EXPRESSION TAG SEQADV 2Y1Z GLY A 120 UNP P02511 ARG 120 ENGINEERED MUTATION SEQADV 2Y1Z MET A 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQADV 2Y1Z GLY B 64 UNP P02511 EXPRESSION TAG SEQADV 2Y1Z ALA B 65 UNP P02511 EXPRESSION TAG SEQADV 2Y1Z MET B 66 UNP P02511 EXPRESSION TAG SEQADV 2Y1Z GLY B 120 UNP P02511 ARG 120 ENGINEERED MUTATION SEQADV 2Y1Z MET B 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQRES 1 A 94 GLY ALA MET GLU MET ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 A 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 A 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 A 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 A 94 ARG GLU PHE HIS GLY LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 A 94 ASP PRO LEU THR ILE THR SER SER MET SER SER ASP GLY SEQRES 7 A 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 A 94 PRO GLU ARG SEQRES 1 B 94 GLY ALA MET GLU MET ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 B 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 B 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 B 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 B 94 ARG GLU PHE HIS GLY LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 B 94 ASP PRO LEU THR ILE THR SER SER MET SER SER ASP GLY SEQRES 7 B 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 B 94 PRO GLU ARG HET MRD A1152 8 HET MPD A1153 8 HET MRD B1151 8 HET MRD B1152 8 HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL FORMUL 3 MRD 3(C6 H14 O2) FORMUL 4 MPD C6 H14 O2 FORMUL 5 HOH *14(H2 O) HELIX 1 1 SER A 85 GLU A 87 5 3 HELIX 2 2 ASP A 129 ILE A 133 5 5 HELIX 3 3 SER B 85 GLU B 87 5 3 HELIX 4 4 ASP B 129 ILE B 133 5 5 SHEET 1 AA 4 MET A 68 LEU A 70 0 SHEET 2 AA 4 ARG A 74 ASP A 80 -1 O SER A 76 N ARG A 69 SHEET 3 AA 4 VAL A 142 PRO A 148 -1 O LEU A 143 N LEU A 79 SHEET 4 AA 4 THR A 134 MET A 137 -1 O THR A 134 N ASN A 146 SHEET 1 AB 6 LEU A 89 LEU A 94 0 SHEET 2 AB 6 VAL A 97 GLU A 105 -1 O VAL A 97 N LEU A 94 SHEET 3 AB 6 GLY A 112 ARG A 123 -1 O ARG A 116 N HIS A 104 SHEET 4 AB 6 GLY B 112 ARG B 123 -1 O PHE B 113 N LYS A 121 SHEET 5 AB 6 VAL B 97 GLN B 108 -1 O ILE B 98 N TYR B 122 SHEET 6 AB 6 LEU B 89 LEU B 94 -1 O LYS B 90 N HIS B 101 SHEET 1 BA 4 MET B 66 LEU B 70 0 SHEET 2 BA 4 ARG B 74 ASP B 80 -1 O SER B 76 N ARG B 69 SHEET 3 BA 4 VAL B 142 PRO B 148 -1 O LEU B 143 N LEU B 79 SHEET 4 BA 4 THR B 134 MET B 137 -1 O THR B 134 N ASN B 146 CISPEP 1 ASP B 109 GLU B 110 0 -2.65 SITE 1 AC1 3 SER A 135 SER A 136 MET B 137 SITE 1 AC2 3 GLU A 110 GLY A 112 PHE A 113 SITE 1 AC3 5 MET A 137 SER A 138 SER B 135 MET B 137 SITE 2 AC3 5 LEU B 143 SITE 1 AC4 4 ARG A 123 GLU B 110 HIS B 111 GLY B 112 CRYST1 60.730 60.730 100.150 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016466 0.009507 0.000000 0.00000 SCALE2 0.000000 0.019014 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009985 0.00000 MTRIX1 1 -0.996000 -0.088000 0.032000 60.04700 1 MTRIX2 1 -0.086000 0.994000 0.062000 1.95000 1 MTRIX3 1 -0.037000 0.059000 -0.998000 15.32900 1